Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The altering cellular components and function in tumor microenvironment during remissive and relapsed stages of anti-CD19 CAR T-cell treated lymphoma mice. | Front Immunol | 2023 | 36761733 | PubTator, text mining | PubMed |
| IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM. | J Immunother Cancer | 2023 | 36759014 | PubTator, text mining | PubMed |
| IL-13RA2 downregulation in fibroblasts promotes keloid fibrosis via JAK/STAT6 activation. | JCI Insight | 2023 | 36757802 | PubTator, text mining | PubMed |
| Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma. | Neurooncol Adv | 2023 | 36751672 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future. | J Immunother Precis Oncol | 2023 | 36751657 | PubTator, text mining | PubMed |
| Sensitization of colonic nociceptors by IL-13 is dependent on JAK and p38 MAPK activity. | Am J Physiol Gastrointest Liver Physiol | 2023 | 36749569 | PubTator, text mining | PubMed |
| H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics. | Expert Opin Ther Targets | 2023 | 36744399 | PubTator, text mining | PubMed |
| Polydopamine-based loaded temozolomide nanoparticles conjugated by peptide-1 for glioblastoma chemotherapy and photothermal therapy. | Front Pharmacol | 2023 | 36744246 | PubTator, text mining | PubMed |
| Systemic inflammatory regulators and risk of acute-on-chronic liver failure: A bidirectional mendelian-randomization study. | Front Cell Dev Biol | 2023 | 36743413 | PubTator, text mining | PubMed |
| Exploration of the shared pathways and common biomarker PAN3 in ankylosing spondylitis and ulcerative colitis using integrated bioinformatics analysis. | Front Immunol | 2023 | 36742304 | PubTator, text mining | PubMed |
| Recurrent Glioblastoma: Ongoing Clinical Challenges and Future Prospects. | Onco Targets Ther | 2023 | 36721854 | PubTator, text mining | PubMed |
| CAR T cells: engineered immune cells to treat brain cancers and beyond. | Mol Cancer | 2023 | 36721153 | PubTator, text mining | PubMed |
| Next-generation antigen-presenting cell immune therapeutics for gliomas. | J Clin Invest | 2023 | 36719372 | PubTator, text mining | PubMed |
| CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances. | Mol Cancer | 2023 | 36717905 | PubTator, text mining | PubMed |
| Stromal regulation of the intestinal barrier. | Mucosal Immunol | 2023 | 36708806 | PubTator, text mining | PubMed |
| Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment. | Exp Hematol Oncol | 2023 | 36707873 | PubTator, text mining | PubMed |
| Shedding light on key pharmacological knowledge and strategies for pediatric atopic dermatitis. | Expert Rev Clin Pharmacol | 2023 | 36705936 | PubTator, text mining | PubMed |
| Interleukin-2 family cytokines: An overview of genes, expression, signaling and functional roles in teleost. | Dev Comp Immunol | 2023 | 36696924 | PubTator, text mining | PubMed |
| Artificial neural network identified the significant genes to distinguish Idiopathic pulmonary fibrosis. | Sci Rep | 2023 | 36681777 | PubTator, text mining | PubMed |
| Antioxidant and Anti-Inflammatory Effects of 6,3',4´- and 7,3´,4´-Trihydroxyflavone on 2D and 3D RAW264.7 Models. | Antioxidants (Basel) | 2023 | 36671068 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=26